XML 32 R23.htm IDEA: XBRL DOCUMENT v3.19.2
Florida Oncology Partners (Details)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2018
USD ($)
shares
Jun. 30, 2019
USD ($)
Jun. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
Term
Jun. 30, 2018
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2011
USD ($)
Dec. 31, 2017
USD ($)
Nov. 30, 2017
USD ($)
Sep. 22, 2017
USD ($)
Florida Oncology Partners [Abstract]                      
Due from related parties $ 1,141,000 $ 0   $ 0   $ 1,141,000          
Lease obligations   179,000   179,000              
Condensed Income Statement Information [Abstract]                      
Patient revenue   825,000 $ 1,121,000 1,666,000 $ 1,986,000            
USNC's equity in (loss) earnings of FOP   (513,000) (160,000) $ (746,000) (190,000)            
FOP and FOPRE [Member]                      
Florida Oncology Partners [Abstract]                      
Down payment of capital leases             $ 1,000,000        
Monthly payments for capital leases             $ 172,000        
FOP [Member]                      
Florida Oncology Partners [Abstract]                      
Lease term       7 years              
Capital lease obligation               $ 5,800,000      
Percentage of guarantee obligations               25.00%      
Common stock awarded as a part of bankruptcy proceedings (in shares) | shares 10,820                    
Due from related parties $ 223,000 120,000   $ 120,000   223,000          
Lease obligations   17,600,000   17,600,000              
Outstanding amount 735,000 $ 600,000   600,000   735,000          
Accrued interest       $ 53,000   30,000          
Note bearing interest   6.00%   6.00%              
Allowance for note receivable 218,000 $ 523,000   $ 523,000   218,000          
Reduced carrying value of note 517,000 77,000   77,000   517,000          
Increase in allowance       305,000              
Condensed Income Statement Information [Abstract]                      
Patient revenue   891,000 1,706,000 1,922,000 2,306,000            
Rental income   181,000 408,000 362,000 890,000            
Net (loss) income   (409,000) 577,000 (591,000) 109,000            
USNC's equity in (loss) earnings of FOP   (99,000) 139,000 (143,000) 26,000            
Condensed Balance Sheet Information [Abstract]                      
Current assets 401,000 586,000   586,000   401,000          
Noncurrent assets 16,570,000 3,835,000   3,835,000   16,570,000          
Total assets 16,971,000 4,421,000   4,421,000   16,971,000          
Current liabilities 3,974,000 4,530,000   4,530,000   3,974,000          
Noncurrent liabilities 15,360,000 2,840,000   2,840,000   15,360,000          
Deficit (2,363,000) (2,949,000)   (2,949,000)   (2,363,000)          
Total liabilities and equity (deficit) $ 16,971,000 4,421,000   $ 4,421,000   $ 16,971,000          
FOP [Member] | Maximum [Member]                      
Florida Oncology Partners [Abstract]                      
Amount of guarantee obligations               $ 1,433,000      
FOP [Member] | Office Space [Member]                      
Florida Oncology Partners [Abstract]                      
Lease term       10 years              
Loan amount                   $ 4,106,000  
Outstanding Loan   3,394,000 $ 3,919,000 $ 3,394,000 $ 3,919,000            
Debt maturity period       7 years              
FOP [Member] | Radiation Therapy Center [Member]                      
Florida Oncology Partners [Abstract]                      
Lease term       10 years              
Capital lease obligation                     $ 14,321,000
Monthly payments for capital leases   163,200   $ 163,200         $ 160,000    
Percentage of increase of monthly payments each year       2.00%              
Maximum number of additional terms extended | Term       3              
Extension of agreement       5 years              
FOP [Member] | Letter of Credit [Member] | Office Space [Member]                      
Florida Oncology Partners [Abstract]                      
Letter of credit, amount   $ 88,000   $ 88,000              
FOP [Member] | USNC [Member]                      
Florida Oncology Partners [Abstract]                      
Ownership percentage   24.00%   24.00%